商业来源在新药采用中的作用。

The role of commercial sources in the adoption of a new drug.

作者信息

Peay M Y, Peay E R

机构信息

Department of Psychiatry, University of Adelaide, Australia.

出版信息

Soc Sci Med. 1988;26(12):1183-9. doi: 10.1016/0277-9536(88)90149-9.

DOI:10.1016/0277-9536(88)90149-9

PMID:2905075

Abstract

The goal of this study was to focus on the adoption process for a specific new drug upon its introduction to the marketplace. The reception of temazepam by doctors was investigated in interviews with 124 specialists and general practitioners. Their response to this new drug at different stages of the adoption process was related to contact with drug information sources and to characteristics of the doctor and practice. Within about 13 months after its release, 71% were familiar with temazepam, 48% had prescribed it, and 27% now preferred it to the alternatives. Contact with the detailman regarding this drug was the most consistent predictor of favourable reception. Results suggest that the adoption of the new drug was related to commercial forces rather than to a doctor's professional involvements.

摘要

本研究的目的是关注一种特定新药进入市场后的采用过程。通过对124名专科医生和全科医生的访谈，调查了他们对替马西泮的接受情况。他们在采用过程不同阶段对这种新药的反应与药物信息来源的接触以及医生和诊所的特征有关。在该药上市约13个月内，71%的人熟悉替马西泮，48%的人开过该药，27%的人现在比其他同类药更倾向于使用它。与药品推销员就该药的接触是对其接受良好的最一致预测因素。结果表明，新药的采用与商业力量有关，而非与医生的专业参与有关。